agilon health, inc. Annual Report - How They Did This Year (2025)

This summary provides a clear and concise overview of agilon health's performance for the year ended December 31, 2025. We aim to present the key financial and operational highlights in an accessible way, helping you understand the company's trajectory as an investor or prospective investor.

agilon health, inc. (NYSE: AGL), headquartered in Westerville, Ohio, is a healthcare company focused on transforming how healthcare is delivered.

---

Business Overview

agilon health leads the shift towards value-based care, primarily partnering with primary care physicians to manage the health of senior patients. Unlike the traditional "fee-for-service" model, where providers are paid for each service rendered, agilon health's model compensates physicians for keeping patients healthy, emphasizing preventive care and improved patient outcomes.

The company operates through two main segments: Medical Services and Other Operating.

• The Medical Services segment is agilon health's core business. Here, the company partners with physician groups to deliver value-based care, primarily through government programs such as ACO REACH and CMS ACO Models.
• The Other Operating segment encompasses smaller, non-core activities.

---

Financial Performance

Financial Performance Highlights (Year Ended December 31):

• Revenue: agilon health achieved robust growth, with total revenue reaching $6.5 billion in 2025. This marks a significant increase from $5.2 billion in 2024 and $4.0 billion in 2023, reflecting the company's expanding physician network and growing patient base within its value-based care models.
• Net Income/Loss: While revenue grew, agilon health continued to invest heavily in its expansion. The company reported a Net Loss of $150 million in 2025, an improvement from a Net Loss of $280 million in 2024 and $350 million in 2023. This trend indicates progress towards profitability as its value-based care model matures.
• Medical Margin: This key metric, which represents revenue from patient care minus direct medical costs, showed improvement. This indicates better cost management and care coordination within agilon health's operations.

---

Management Discussion and Analysis (MD&A) Highlights

Management's discussion of the company's financial condition and results of operations highlighted several key developments and strategic decisions during the year:

• Strategic Focus: A significant strategic move involved the discontinuation of MDX Hawaii operations, completed in Q2 2025. agilon health made this decision to streamline operations and focus resources on its core, high-growth value-based care markets. While the exit resulted in a one-time charge of approximately $25 million in 2025, management expects it to improve long-term profitability and operational efficiency.
• Physician Network Expansion: agilon health successfully expanded its network by adding new physician partners and entering several new geographies. This growth increased the total number of patients whose care agilon health manages (referred to as "attributed patient lives") in 2025, serving as a primary driver of the reported revenue growth.
• Legal Matters: The company continues to navigate "consolidated securities matters" (class-action lawsuits alleging misleading statements to investors) and "derivative matters" (shareholder lawsuits alleging breach of fiduciary duty by management). These ongoing legal actions carry uncertain outcomes. The company has provisioned for potential liabilities, and these matters pose potential financial and reputational risks. Management is actively defending these actions.

---

Financial Health

agilon health maintains a solid financial position to support its growth initiatives.

• Cash and Investments: As of December 31, 2025, the company held $400 million in cash and cash equivalents. It also held $150 million in corporate debt securities and U.S. Treasury securities, providing a strong liquidity buffer.
• Debt Structure:
  • agilon health has a Secured Term Loan Facility with an outstanding principal of $1.0 billion, which matures in 2028.
  • A Secured Revolving Facility provides access to $200 million in additional capital. Approximately $50 million is currently drawn, and this facility matures in 2027, offering flexibility for working capital needs.
  • The company also utilizes standby letters of credit and surety bonds totaling approximately $30 million as financial guarantees for various operational requirements.
• Cash Flow: Cash flow from operations turned positive in 2025, reaching $80 million. This indicates improving operational efficiency and a healthier path towards self-funding future growth.

---

Risk Factors

Key risks that could materially affect agilon health's business, financial condition, and results of operations include:

• Customer Concentration: A significant portion of agilon health's revenue comes from a few large payors (insurance companies). For instance, its top three payors accounted for approximately 60% of total revenue in 2025. Any reduction in business from these key partners could materially impact the company's financial performance.
• Regulatory Dependence: agilon health's business model relies heavily on government healthcare programs like ACO REACH and CMS ACO Models. Changes in these programs, such as adjustments to reimbursement rates, quality metrics, or eligibility requirements, could directly affect the company's revenue and profitability.
• Legal and Litigation Risks: The ongoing securities and derivative lawsuits pose a risk of significant financial penalties, adverse judgments, or settlements, as well as potential reputational damage.
• Competition: The value-based care market is becoming increasingly competitive. New entrants and established healthcare providers are expanding their own value-based offerings, requiring agilon health to continually innovate and demonstrate superior outcomes to maintain its market position.
• Physician Partner Dependence: The company's success relies heavily on its ability to attract, retain, and effectively partner with primary care physicians. Any challenges in these relationships could impact patient enrollment and care delivery.

---

Competitive Position

agilon health differentiates itself through deep partnerships with local primary care physicians. It provides these physicians with the technology, capital, and administrative support they need to thrive in value-based care. The company's focus on senior patients and strong relationships with payors give it a competitive edge. agilon health's integrated platform and proven model for transitioning physician groups to value-based care are key strengths in a fragmented market.

---

Future Outlook

agilon health anticipates continued revenue growth in 2026, driven by the expansion of its physician network and an increasing number of attributed patient lives. The company expects to further narrow its net losses as its value-based care models mature and it achieves greater operational efficiencies.

agilon health focuses on executing its growth strategy, which includes:

• Expanding its physician partner network in existing and new geographies.
• Deepening engagement with existing partners to drive better patient outcomes and higher medical margins.
• Leveraging technology and data analytics to enhance care coordination and efficiency.

The company projects to achieve positive Adjusted EBITDA. While pursuing its growth objectives, agilon health will continue to carefully manage its legal and regulatory risks.

---

This summary offers a clearer, more detailed picture of agilon health's performance and outlook, providing a stronger foundation for your investment decisions.